Sjøgren Thea, Islam Shahinul, Filippov Igor, Jebrzycka Adrianna, Sulen André, Breivik Lars E, Hellesen Alexander, Jørgensen Anders P, Lima Kari, Tserel Liina, Kisand Kai, Peterson Pärt, Ranki Annamari, Husebye Eystein S, Oftedal Bergithe E, Wolff Anette S B
Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Medicine, Haukeland University Hospital, Bergen, Norway.
iScience. 2024 Mar 27;27(4):109610. doi: 10.1016/j.isci.2024.109610. eCollection 2024 Apr 19.
Immune tolerance fails in autoimmune polyendocrine syndrome type 1 (APS-1) because of mutations. We have used single cell transcriptomics to characterize regulatory T cells (Tregs) sorted directly from blood and from expanded Tregs in APS-1 patients compared to healthy controls. We revealed only CD52 and LTB (down) and TXNIP (up) as consistently differentially expressed genes in the datasets. There were furthermore no large differences of the TCR-repertoire of expanded Tregs between the cohorts, but unique patients showed a more restricted use of specific clonotypes. We also found that expanded Tregs from APS-1 patients had similar suppressive capacity as controls in co-culture assays, despite expanding faster and having more exhausted cells. Our results suggest that APS-1 patients do not have intrinsic defects in their Treg functionality, and that their Tregs can be expanded for potential therapeutic applications.
由于基因突变,自身免疫性多内分泌腺病1型(APS-1)患者的免疫耐受功能失效。我们运用单细胞转录组学技术,对从APS-1患者血液中直接分选的调节性T细胞(Tregs)以及体外扩增后的Tregs进行特征分析,并与健康对照进行比较。我们发现,数据集中仅CD52和LTB(下调)以及TXNIP(上调)是持续差异表达的基因。此外,不同队列中扩增后的Tregs的TCR库没有显著差异,但个别患者表现出对特定克隆型的使用更为受限。我们还发现,尽管APS-1患者扩增后的Tregs增殖更快且耗竭细胞更多,但在共培养实验中,其抑制能力与对照相似。我们的结果表明,APS-1患者的Treg功能没有内在缺陷,其Tregs可以扩增用于潜在的治疗应用。